Publications

2026 | Transplantation and Cellular Therapy

Factors associated with receipt of allogeneic hematopoietic cell transplant and NMDP donor search in older adults with acute myeloid leukemia.

Authors:

Preussler JM, Meyer CL, Burns LJ, Ouayogodé MH, Burns M

2026 | Current opinion in immunology

Optimal donor selection for transplant to reduce GVHD risk and augment graft-versus-malignancy efficacy.

Authors:

Shaffer BC, Shaw BE

2026 | Blood

Extended HLA haplotypes and transplant survival.

Authors:

Petersdorf EW, McKallor C, Malkki M, He M, Spellman SR, Gooley TA, Stevenson PA

2026 | Transplantation and Cellular Therapy

Factors associated with pre-donation health-related quality-of-life among pediatric sibling hematopoietic cell donors; A DonorKids QL study.

Authors:

Switzer GE, Bruce JG, Shaw BE, Kuniyil V, Varni JW, Butler BJ, Erickson C, Mussetter A, Neutzling A, Abdel-Azim H, Aguayo-Hiraldo P, Anderson EJ, Aquino VM, Boone K, 15. Boulad F, Chewning JH, Cooper J, Dahlberg A, 19. Dvorak CC, Galvez-Silva J, Haight AE, Hoag JA, Hudspeth M, Jacobsohn D, Kasow KA, Kitko CL, Krishnamurti L, Madden L, Miller HK, Morales E, Olson TS, Pawlowska AB, Prasad VK, Quigg TC, Scaradavou A, Shah NC, Shenoy S, Terwilliger NB, Wiener L, Yanik GA, Yu LC, Pulsipher MA

2026 | Blood Cancer Journal

Safety and efficacy of ciltacabtagene autoleucel for relapsed/refractory multiple myeloma: A CIBMTR study.

Authors:

Hansen DK, Dima D, Mian H, Devos J, Brazauskas R, Oloyede T, Afrough A, Ahmed N, Anderson L, Banerjee R, Berdeja JG, Bidikian A, Dhakal B, Dias A, Efebera Y, Faisal MS, Gowda L, Hashmi H, Mirza AS, Mohan M, Narra R, Rosko AE, Schroeder M, Nishihori T, Landau H, Usmani S, Pasquini MC, Akhtar OS, Sidana S, Patel KK

2026 | HLA

The phenotype list string grammar for enhanced protein and antigen reporting in the Immunogenetic context.

Authors:

Mack SJ, Brown NK, Gragert L, Hofmann JA, Lemieux W, Matern BM, Osoegawa K, Sauter J, Maiers M, Spierings E

2026 | Blood Advances

Antigen-specific T cell responses to SARS-CoV-2 vaccination after hematopoietic cell transplant or CAR T cell therapy.

Authors:

Einarsdottir, S, Fei, T, Singh, K, Martens, MJ, Young, J, Bhavsar, K, Kou, J, Chen, M, Lee, LW, Baluch, A, Dhodapkar, M, Nakamura, R, Peyton, K, Shahid, Z, Armistead, P, McCarty, J, Westervelt, P, McGuirk, J, Hamadani, M, Sharon, E, Spahn, A, Toor, A, Waldvogel, S, Greenberger, L, Auletta, J, Horowitz, M, Riches, M, Hosszu, K, Hill, J, DeWolf, S, Perales, M

2026 | American Journal of Hematology

Clinical, genetic, and pathologic variability in myelodysplastic syndromes and precursor conditions across race, ethnicity, and sex.

Authors:

Gillis N, Colin-Leitzinger C, Tang YH, Otterstatter M, Sherman S, Zhang L, Moscinski LC, Walker ME, Painter JS, Abel GA, Al Baghdadi T, Deeg HJ, Foran JM, Gore SD, Harrington AM, Kroft SH, Liu JJ, Saber W, Virani S, Bejar R, Lindsley RC, Padron E, Walter MJ, Komrokji R, DeZern AE, Sekeres MA

2026 | Transplantation and Cellular Therapy

Statistical methods for CAR-T cell therapy outcomes: A review and practical considerations.

Authors:

Kim S, Pasquini MC, Ahn KW, Logan B, Brazauskas R, Chen M, Moskop A

2026 | HLA

Nomenclature for Factors of the HLA System, 2026.

Authors:

Marsh SGE, Osoegawa K, Bodmer WF, Bontrop RE, Carrington MN, Erlich HA, Heidt S, Holdsworth R, Mayr WR, Maiers M, Parham P, Petersdorf EW, Robinson J, Trowsdale J, Fernández-Viña M

2026 | Journal of Clinical Oncology

Optimizing Haploidentical Donor Selection for Pediatric Hematopoietic Cell Transplant.

Authors:

Liberio N, Allbee-Johnson M, Ahn KW, Moskop A, Phelan R, Shaw BE, Page KM, Schultz KR, Phillips CL, Mehta PA, Qayed M, Sharma A, Lipsitt AE, Symons H, Bolaños-Meade J, Kharbanda S, Dvorak CC, Kapoor N, Doherty EE, Chavan RS, Broglie L

2026 | Transplantation and Cellular Therapy

Fertility preservation in 2026: Current landscape in Europe and the United States for children and adolescents undergoing hematopoietic stem cell transplantation – recommendations on behalf of the Westhafen Intercontinental Group.

Authors:

Jarisch A, Rotz SJ, Cattoni A, Courbiere B, Lundy SD, Orwig KE, Poirot C, Dalle JH, Phelan R, Diesch-Furlanetto T

2026 | The Journal of Clinical Investigation

The BIOPREVENT machine-learning algorithm predicts chronic graft-versus-host disease and mortality risk using posttransplant biomarkers.

Authors:

Martens, MJ, Dutta, D, Yu, Y, Rein, LE, Ritz, J, Logan, BR, Paczesny, S

2026 | Statistics in Medicine

Rforce: random forests for composite endpoints.

Authors:

Wang Y, Kim S, Lin CW, Ahn KW

2026 | Current Oncology

Real-world outcomes of axicabtagene ciloleucel for treatment of relapsed or refractory large B-cell lymphoma in Canada.

Authors:

Lemieux C, Kuruvilla J, Shafey M, Davison K, Paulson K, Li SZL, Billen L, Nissen F, Wang HL, Kim JJ, Lee G, Hu ZH, Logan B, Feng Z, Pasquini MC, Hay K

2026 | JCO Precision Oncology

Novel genomic biomarkers significantly improve post-HCT relapse risk stratification for patients with myelodysplastic neoplasms.

Authors:

Zhang T, Auer PL, Dong J, Chen Z, Spellman SR, Saber W, Bolon YT

2026 | iScience

Autoimmune HLA alleles and neoantigens predict myelodysplastic syndrome outcomes after allogeneic HSCT: a CIBMTR analysis.

Authors:

Sears T, Kurzrock R, Zhang T, Dong J, Spellman S, Goodman AM, Bolon YT, Chen Z, Auer P, Saber W, Carter H

2026 | Transplantation and Cellular Therapy

Donor search and selection strategy to facilitate comparable transplant rates across donor search prognosis groups: A report from the BMT CTN 1702 trial

Authors:

Pidala, J, Logan, BR, Lee, SJ, Shaw, BE, Devine, SM, Ciurea, SO, Horowitz, M, He, N, Pusic, I, Srour, SA, Arai, S, Juckett, M, Uberti, J, Hill, L, Vasu, S, Hogan, WJ, Hayes-Lattin, B, Westervelt, P, Bashey, A, Farhadfar, N, Grunwald, MR, Leifer, E, Symons, H, Saad, A, Vogel, J, Buck, K, Erickson, C, Dehn, JG

2026 | Transplantation and Cellular Therapy

Impact of complete response on long-term survival in patients with relapsed or refractory large B‑cell lymphoma: A CIBMTR prospective study and SLR/meta-analysis.

Authors:

Ghobadi A, Anagnostou T, Azzi J, Hamadani M, Logan B, Ahmed S, Bharadwaj S, Baird JH, Jacobson C, Locke FL, Ulrickson M, Reagan PM, Hemmer MT, Hu ZH, Luo ZC, Wang HL, Jung AS, Nahas M, Best T, Beygi S, Pasquini MC

2026 | Journal of Cancer Survivorship

Visualizing health-related quality of life (HRQoL): Understanding comprehension of HRQoL graphs in the allogeneic hematopoietic cell transplant setting.

Authors:

Cusatis R, Kapfhammer M, Rein L, Szabo A, Reed-Thryselius S, Phelan R, Bingen K, Runaas L, Shaw BE, Flynn KE